Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
Nitroxinil is an antiparasitic agent primarily used in veterinary medicine, particularly for the treatment of liver fluke infections in sheep and cattle. It functions by uncoupling oxidative phosphorylation in the parasite, leading to energy depletion and eventual death of the organism. Nitroxinil is structurally characterized by its nitrophenolic composition, which contributes to its efficacy against helminths. The compound is typically administered via injection, allowing for rapid absorption and action. Nitroxinil's gene location and specific molecular interactions are not extensively documented in the context of biosimilars, as it is not a biological product but rather a synthetic chemical compound. However, its mechanism of action and pharmacokinetics are well-studied, ensuring its continued use in agricultural settings.
仅用于科研。不用于诊断过程。未经明确授权不得转售。